Curat Global’s Biogen BIIB Stock Holding History

Curat Global’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$92.2K	Hold	503	–	–	0.09%	138
2025 Q4	$88.5K	Hold	503	–	–	0.1%	140
2025 Q3	$70.5K	Hold	503	–	–	0.07%	161
2025 Q2	$63.2K	Hold	503	–	–	0.06%	165
2025 Q1	$68.8K	Buy	+503	New	+$71.9K	0.08%	165

Other funds holding BIIB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Curat Global's BIIB Position: Q1 2026 in Review

Curat Global held its Biogen (BIIB) position steady in Q1 2026 at 503 shares worth $92.2K. The position accounts for 0.09% of the portfolio, ranked #138.

Curat Global first reported a position in BIIB in Q1 2025 and has held it in 5 quarters since. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

Curat Global held 503 shares of Biogen worth $92.2K as of Q1 2026.
Curat Global left its Biogen share count unchanged in Q1 2026.
Biogen made up 0.09% of Curat Global's portfolio in Q1 2026, its #138 holding.
Curat Global first reported a position in Biogen in Q1 2025 and has held it in 5 quarters since.
1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Curat Global's 13F filing for Q1 2026, filed 21 Apr 2026.